RNAC logo

Cartesian Therapeutics (RNAC) Current Liabilities

Annual Current Liabilities

$68.21 M
+$43.13 M+172.00%

31 December 2023

RNAC Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Liabilities

$21.41 M
-$4.71 M-18.04%

01 September 2024

RNAC Quarterly Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

RNAC Current Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+172.0%+7.3%
3 y3 years-16.4%-77.6%
5 y5 years+94.1%-27.4%

RNAC Current Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-16.4%+172.0%-77.6%+7.3%
5 y5 years-16.4%+172.0%-77.6%+7.3%
alltimeall time-16.4%+835.6%-77.6%+238.8%

Cartesian Therapeutics Current Liabilities History

DateAnnualQuarterly
Sept 2024
-
$21.41 M(-18.0%)
June 2024
-
$26.11 M(-28.8%)
Mar 2024
-
$36.65 M(-46.3%)
Dec 2023
$68.21 M(+172.0%)
$68.21 M(+242.1%)
Sept 2023
-
$19.94 M(-32.1%)
June 2023
-
$29.37 M(+10.7%)
Mar 2023
-
$26.53 M(+5.8%)
Dec 2022
$25.08 M(-65.3%)
-
Dec 2022
-
$25.08 M(+5.7%)
Sept 2022
-
$23.73 M(-29.7%)
June 2022
-
$33.76 M(-14.0%)
Mar 2022
-
$39.25 M(-45.7%)
Dec 2021
$72.25 M(-11.4%)
$72.25 M(-24.4%)
Sept 2021
-
$95.62 M(+9.5%)
June 2021
-
$87.30 M(+3.2%)
Mar 2021
-
$84.61 M(+3.8%)
Dec 2020
$81.55 M
$81.55 M(+5.9%)
Sept 2020
-
$77.00 M(+242.1%)
June 2020
-
$22.51 M(-25.1%)
DateAnnualQuarterly
Mar 2020
-
$30.07 M(-13.9%)
Dec 2019
$34.94 M(-0.6%)
$34.94 M(+18.5%)
Sept 2019
-
$29.48 M(-7.6%)
June 2019
-
$31.91 M(-3.4%)
Mar 2019
-
$33.05 M(-6.0%)
Dec 2018
$35.14 M(+220.3%)
$35.14 M(+1.5%)
Sept 2018
-
$34.63 M(+149.3%)
June 2018
-
$13.89 M(+17.6%)
Mar 2018
-
$11.81 M(+7.6%)
Dec 2017
$10.97 M(-19.9%)
$10.97 M(-3.1%)
Sept 2017
-
$11.32 M(-43.5%)
June 2017
-
$20.05 M(+50.7%)
Mar 2017
-
$13.30 M(-2.9%)
Dec 2016
$13.71 M(+88.0%)
$13.71 M(+78.2%)
Sept 2016
-
$7.69 M(-14.0%)
June 2016
-
$8.94 M(+41.5%)
Mar 2016
-
$6.32 M(-13.3%)
Dec 2015
$7.29 M(-21.0%)
$7.29 M
Dec 2014
$9.23 M
-

FAQ

  • What is Cartesian Therapeutics annual total current liabilities?
  • What is the all time high annual current liabilities for Cartesian Therapeutics?
  • What is Cartesian Therapeutics annual current liabilities year-on-year change?
  • What is Cartesian Therapeutics quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Cartesian Therapeutics?
  • What is Cartesian Therapeutics quarterly current liabilities year-on-year change?

What is Cartesian Therapeutics annual total current liabilities?

The current annual current liabilities of RNAC is $68.21 M

What is the all time high annual current liabilities for Cartesian Therapeutics?

Cartesian Therapeutics all-time high annual total current liabilities is $81.55 M

What is Cartesian Therapeutics annual current liabilities year-on-year change?

Over the past year, RNAC annual total current liabilities has changed by +$43.13 M (+172.00%)

What is Cartesian Therapeutics quarterly total current liabilities?

The current quarterly current liabilities of RNAC is $21.41 M

What is the all time high quarterly current liabilities for Cartesian Therapeutics?

Cartesian Therapeutics all-time high quarterly total current liabilities is $95.62 M

What is Cartesian Therapeutics quarterly current liabilities year-on-year change?

Over the past year, RNAC quarterly total current liabilities has changed by +$1.47 M (+7.35%)